Encompass Health Corp (EHC) stock
EHCNYSEServices-HospitalsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 16/3013% above fair value
$140.83−1.41 (-0.99%)
Close on Nov 12, 2026Market cap $13.89BP/E 22.9Yield 0.51%
Encompass Health ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Encompass Health's ebitda for the twelve months ending Dec 31, 2022 was $783.10M, up 0.5% year over year. For fiscal 2022 it was $783.10M, up 0.5% from the year before. The highest annual figure on record is $830.80M in fiscal 2019.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $783.10M | +0.5% |
| FY2021 | Dec 31, 2021 | $779.20M | +1.6% |
| FY2020 | Dec 31, 2020 | $766.90M | -7.7% |
| FY2019 | Dec 31, 2019 | $830.80M | +10.1% |
| FY2018 | Dec 31, 2018 | $754.90M | -0.9% |
| FY2017 | Dec 31, 2017 | $762.10M | +0.2% |
| FY2016 | Dec 31, 2016 | $760.70M | +21.6% |
| FY2015 | Dec 31, 2015 | $625.40M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | $215.20M | +16.3% |
| Q3 FY2022 | Sep 30, 2022 | $189.60M | -3.7% |
| Q2 FY2022 | Jun 30, 2022 | $189.10M | -10.0% |
| Q1 FY2022 | Mar 31, 2022 | $189.20M | -7.9% |
| Q4 FY2021 | Dec 31, 2021 | $185.10M | -2.9% |
| Q3 FY2021 | Sep 30, 2021 | $196.90M | -7.3% |
| Q2 FY2021 | Jun 30, 2021 | $210.20M | +44.1% |
| Q1 FY2021 | Mar 31, 2021 | $205.50M | -5.8% |
| Q4 FY2020 | Dec 31, 2020 | $190.60M | -4.5% |
| Q3 FY2020 | Sep 30, 2020 | $212.30M | +2.9% |
| Q2 FY2020 | Jun 30, 2020 | $145.90M | -28.9% |
| Q1 FY2020 | Mar 31, 2020 | $218.10M | -0.7% |
| Q4 FY2019 | Dec 31, 2019 | $199.60M | +36.4% |
| Q3 FY2019 | Sep 30, 2019 | $206.30M | +0.3% |
| Q2 FY2019 | Jun 30, 2019 | $205.30M | -0.8% |
| Q1 FY2019 | Mar 31, 2019 | $219.60M | +12.1% |
| Q4 FY2018 | Dec 31, 2018 | $146.30M | -23.5% |
| Q3 FY2018 | Sep 30, 2018 | $205.70M | +7.5% |
| Q2 FY2018 | Jun 30, 2018 | $207.00M | +10.6% |
| Q1 FY2018 | Mar 31, 2018 | $195.90M | +1.9% |
| Q4 FY2017 | Dec 31, 2017 | $191.30M | +1.1% |
| Q3 FY2017 | Sep 30, 2017 | $191.40M | -0.2% |
| Q2 FY2017 | Jun 30, 2017 | $187.10M | – |
| Q1 FY2017 | Mar 31, 2017 | $192.30M | – |
| Q4 FY2016 | Dec 31, 2016 | $189.30M | – |
| Q3 FY2016 | Sep 30, 2016 | $191.70M | – |
See a number that looks wrong?